Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1184806

Tumor immunotherapy side effects – early recognition and management


Pavlović Ružić, Ira; Zahirović, Dag; Pavlović, Sanja; Belac Lovasić, Ingrid
Tumor immunotherapy side effects – early recognition and management // Libri Oncologici : Croatian Journal of Oncology, 45 (2017), 2-3; 78-80 (recenziran, pregledni rad, znanstveni)


CROSBI ID: 1184806 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Tumor immunotherapy side effects – early recognition and management

Autori
Pavlović Ružić, Ira ; Zahirović, Dag ; Pavlović, Sanja ; Belac Lovasić, Ingrid

Izvornik
Libri Oncologici : Croatian Journal of Oncology (2584-3826) 45 (2017), 2-3; 78-80

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, znanstveni

Ključne riječi
tumor immunotherapy ; side effects ; management of side effects ; checkpoint inhibitors ; anti-CTLA-4 immunotherapy

Sažetak
Implementation of immunotherapy in many cancer types has achieved positive results in tumor control and cure. The concept of immunotherapy is diff erent in comparison with conventional tumor therapies. While chemotherapy, hormonal or biological therapies target tumor cells and mechanisms, immunotherapy targets host immune system. Amplifi cation of defending possibilities or unblocking the control of the immune reactions are used. Besides positive results in tumor control, enhancing immunogenicity can provoke harm to other tissues and systems in form of adverse reactions or unwanted side effects of therapy. Early recognition of side effects is of crucial importance and prompt care can diminish the harm and severity. Knowledge about side effects is needed, therefore good education of all medical personnel included in treatment as well as patient education must be assured prior and thorough the treatment. Writt en guidelines are provided and easy reachable and must be used.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Ustanove:
Medicinski fakultet, Rijeka,
Klinički bolnički centar Rijeka

Poveznice na cjeloviti tekst rada:

hrcak.srce.hr

Citiraj ovu publikaciju:

Pavlović Ružić, Ira; Zahirović, Dag; Pavlović, Sanja; Belac Lovasić, Ingrid
Tumor immunotherapy side effects – early recognition and management // Libri Oncologici : Croatian Journal of Oncology, 45 (2017), 2-3; 78-80 (recenziran, pregledni rad, znanstveni)
Pavlović Ružić, I., Zahirović, D., Pavlović, S. & Belac Lovasić, I. (2017) Tumor immunotherapy side effects – early recognition and management. Libri Oncologici : Croatian Journal of Oncology, 45 (2-3), 78-80.
@article{article, author = {Pavlovi\'{c} Ru\v{z}i\'{c}, Ira and Zahirovi\'{c}, Dag and Pavlovi\'{c}, Sanja and Belac Lovasi\'{c}, Ingrid}, year = {2017}, pages = {78-80}, keywords = {tumor immunotherapy, side effects, management of side effects, checkpoint inhibitors, anti-CTLA-4 immunotherapy}, journal = {Libri Oncologici : Croatian Journal of Oncology}, volume = {45}, number = {2-3}, issn = {2584-3826}, title = {Tumor immunotherapy side effects – early recognition and management}, keyword = {tumor immunotherapy, side effects, management of side effects, checkpoint inhibitors, anti-CTLA-4 immunotherapy} }
@article{article, author = {Pavlovi\'{c} Ru\v{z}i\'{c}, Ira and Zahirovi\'{c}, Dag and Pavlovi\'{c}, Sanja and Belac Lovasi\'{c}, Ingrid}, year = {2017}, pages = {78-80}, keywords = {tumor immunotherapy, side effects, management of side effects, checkpoint inhibitors, anti-CTLA-4 immunotherapy}, journal = {Libri Oncologici : Croatian Journal of Oncology}, volume = {45}, number = {2-3}, issn = {2584-3826}, title = {Tumor immunotherapy side effects – early recognition and management}, keyword = {tumor immunotherapy, side effects, management of side effects, checkpoint inhibitors, anti-CTLA-4 immunotherapy} }




Contrast
Increase Font
Decrease Font
Dyslexic Font